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Abstract: The association of angiitis of central nervous system (ACNS) with cerebral amyloid 
angiopathy (CAA) suggests a physiopathological relationship between these two affections. 
Few cases are reported in patients with Alzheimer’s disease (AD). We describe here a 
clinicopathological case associating ACNS, CAA, and AD. We discuss the aetiology of ACNS 
and its relationship with cerebral deposition of beta A4 amyloid protein (βA4).
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Beta A4 amyloid protein (βA4) cerebral amyloid angiopathy (CAA) is a frequent 
disorder which increases with aging (Vinters 1987; Kumar-Singh 2008). It can be 
isolated or associated with Alzheimer’s disease (AD) (Kumar-Singh 2008). In com-
parison, primary angiitis of the central nervous system (PACNS) is quite rare (Kelley 
2004; Jennette and Falk 2007). Nine percent of reported cases had both PACNS and 
CAA (Kelley 2004; Younger 2004; Jennette and Falk 2007). This might suggest a 
physiopathological relationship between these two vascular disorders (Fountain and 
Eberhard 1996; Kumar-Singh 2008). Few previous cases reported the association 
of PACNS and CAA in AD patients (Brotman et al 2000; Jacobs et al 2004). None 
of these cases was autoptic. We describe here a clinicopathological case associating 
ACNS, CAA and AD. We discuss the etiology of ACNS and its relationship with 
cerebral deposition of βA4.
Case report
A 75-year-old woman was referred in acute care for mental deterioration, gait disorder, 
urinal incontinence, and unusual headache progressing over the six months. The 
family reported that the short-term memory loss gradually developed over the last 
two years. The daily activity was disturbed and required the presence of a caregiver. 
The past medical history included hypertension treated with atenolol. The medical 
family history was unremarkable.
On admission, the patient was bedridden. Neurological examination revealed a 
ﬂ  uctuation of vigilance. She was mute and had a bilateral grasp reﬂ  ex. There was no 
motor or sensory deﬁ  cit. General physical examination was normal. Blood pressure 
was 150/70 mmHg and temperature was 37 °C. Complete blood count, liver enzymes 
and serum electrolytes were normal. The results of blood inﬂ  ammatory test were as 
follows: erythrocyte sedimentation rate 35 mm/hour, C-reactive protein 620 mg/dL 
(normal  100), ﬁ  brinogen 51 mg/dL (normal  40). Serum protein electrophoresis 
and immunoelectrophoresis were normal. To rule out a diagnosis of meningitis, a 
lumbar puncture was performed, yielding a clear cerebral spinal ﬂ  uid (CSF) with Vascular Health and Risk Management 2008:4(6) 1472
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78 erythrocytes/mL, 2 leukocytes/mL, 250 mg/dL protein 
(normal  45) with 14.6% IgG in a polyclonal pattern (nor-
mal  10), and 63 mg/dL glucose (normal  75). Bacterial 
examination of the CSF did not show any germ and cultures 
were negative. All serum and CSF tests for infection were 
unremarkable, including herpes simplex virus, varicella 
zoster virus, human immunodeﬁ  ciency virus types 1 and 2, 
cytomegalovirus, mycoplasma pneumoniae, Lyme disease, 
syphilis, mycobacterium tuberculosis, and cryptococcosis. 
Brain computed tomography (CT) scan showed extensive 
hypointensities in the white matter in both hemispheres 
and a mild ventricular enlargement. There was no iodine 
ﬁ  xation. Axial brain magnetic resonance imaging (MRI) 
showed T2-weighted high-intensities in the periventricular 
white matter and was negative in T1-weighted sequences 
with and without gadolinium infusion. On coronal images, 
the left hippocampus was atrophic. Search for antinuclear 
antibody was negative. Because of the severely disabled 
clinical status and the abnormality of the CSF, an intravenous 
corticotherapy was initiated seven day after admission with 
120 mg dexamethasone per day associated with antibiotics. 
Vigilance and mutism improved in few days revealing a severe 
dementia with complete temporo-spatial disorientation. After 
three weeks of corticotherapy, CSF protein concentration 
was 46 mg/dL and C-reactive protein was normal. Brain CT 
scan was unchanged. The neurological status stabilized with 
a severe dementia. Corticosteroids were progressively tapered 
over the next ﬁ  ve weeks and the patient was transferred to a 
geriatric rehabilitation hospital. She died four months later 
of a pulmonary infection.
On postmortem examination, the brain weighed 1180 g. 
Macroscopically, coronal brain slices showed a mild atrophy 
of the left hippocampus and a moderate enlargement of 
the lateral ventricles. The cortical band had a normal 
thickness. Focal small dark red infarcts were disseminated 
in the subcortical white matter of both hemispheres. The 
brainstem and cerebellum were normal. The circle of Willis 
was permeable. Samples of the hippocampus, entorrhinal 
cortex, middle frontal gyrus, superior and middle temporal 
gyri, inferior parietal lobule, and midbrain including the 
basal ganglia were fixed in 10% neutral-formalin and 
examined by light microscopy. On parafﬁ  n-embedded and 
hematoxylin-eosin-safran and congo red stained sections, 
lesions consisted in senile plaques, CAA, angiitis, and micro-
infarcts. Amyloid deposits were present in the neocortex 
of both cerebral lobes where they appeared as amorphous 
material in senile plaques. The wall of numerous vessels 
located in the leptomeningeal space and cortex were also 
inﬁ  ltrated by these amyloid deposits. Inﬂ  ammatory inﬁ  ltrates 
consisting in lymphoid cells and macrophages surrounded 
both amyloid and non amyloid vessels in the leptomeningeal 
space and less frequently in the cortex (Figure 1A). There 
were neither multinucleated giant cells nor ﬁ  brinoid necrosis. 
In addition, numerous vessels including some with amyloid 
deposition showed severe intimal ﬁ  brosis occluding the 
lumen, and suggesting a post inﬂ  ammatory healing process 
(Figure 1B). Multiple disseminated small infarcts were 
observed all over both hemispheres respecting the basal 
ganglia. They were ﬁ  lled with macrophages and surrounded 
by siderophages. Immunohistochemical study showed that 
amyloid deposits, present in the senile plaques and in the wall 
of vessels including some with an inﬂ  ammatory inﬁ  ltrate, 
were stained with βA4 amyloid antigen (DAKO, Glostrup, 
Danemark) (Figure 1C, D). Tau (DAKO) immunolabeled the 
periphery of the majority of amyloid plaques, and deﬁ  ned 
neuritic plaques. Tau protein ﬁ  lamentous accumulation was 
present within the cells bodies of neurons indicating the 
presence of neuroﬁ  brillary tangles, especially in the isocortex 
(Figure 1E). A semiquantitative assessment of neocortical 
senile plaques density was estimated as superior to 17 per 
square millimeter in all the investigated samples of the neo-
cortex. The density of neuroﬁ  brillary tangles was higher in the 
hippocampus and the entorrhinal cortex. In the myocardium, 
the wall of a coronary artery was inﬁ  ltrated by lymphocytes, 
mononuclear cells, and giant multinucleated cells (Figure 1F). 
An interstitial ﬁ  brosis was present between the myocytes, 
likely due to hypertension. Vessel inﬂ  ammatory changes 
were not found in the autopsy samples of lung, kidney, liver, 
spleen, and muscles examined by light microscopy.
Discussion
The patient presented with a high neuropathological 
likelihood of AD according to the National Institute on Aging 
and Reagan Institute criteria with diffuse senile plaques and 
neuroﬁ  brillary tangles in all the neocortex (Hyman 1998). 
Assessment for senile plaques corresponded to a “frequent 
score” according to the CERAD criteria and to a stage V in 
the Braak and Braak classiﬁ  cation (Mirra et al 1991). These 
pathological criteria were associated with a retrospective 
history of cognitive decline over two years before a rapid 
and fatal deterioration. In addition, brain MRI showed left 
hippocampal atrophy. These data were consistent with the 
pathological study and indicated that the patient developed 
AD prior to hospitalization.
In our case, the AD was associated with two cerebrovascular 
pathologies. The ﬁ  rst was CAA as demonstrated by Congo Vascular Health and Risk Management 2008:4(6) 1473
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red staining of blood vessels and βA4 deposition in the wall 
of vessels restricted to the brain. The second was a cerebral 
angiitis which probably explains most of the terminal 
clinical manifestations including gait disorder, unusual and 
persisting headache, diffuse white matter lesions on brain 
imaging, and high CSF protein concentration. There are 
several arguments to consider that it was a PACNS and not 
a secondary ACNS. The clinical presentation of PACNS 
frequently includes dementia and headache. CSF protein 
concentration is elevated in 80% of cases. Cerebral imaging 
usually shows multiple cerebral infarcts, but isolated white 
matter abnormalities have also been reported (Fountain and 
Eberhard 1996; Brotman et al 2000; Jacobs et al 2004). None 
of these signs are speciﬁ  c and pathological study only is able 
to ascertain the diagnosis. Lesions consist in inﬂ  ammatory 
cell inﬁ  ltrates of small and middle sized leptomeningeal and 
cortical arteries with cortical and subcortical infarcts (Younger 
2004). A granulomatous reaction considered as typical of 
PACNS occurs in only half of the pathologically proven cases 
(Kelley 2004; Younger 2004). In the others, inﬂ  ammatory cells 
consist in lymphocytes and monocytes (Kelley 2004; Jennette 
and Falk 2007). In the case reported herein, inﬂ  ammatory 
inﬁ  ltrates were composed of mononuclear cells predominating 
around the vessels. However, in the myocardium, a typical 
granulomatous inﬂ  ammatory reaction was present around 
some vessels. Asymptomatic extracerebral localization of 
the angiitic process is possible. The diagnosis of PACNS 
is usually based on two cerebral examinations which are 
angiographic changes and positive cerebral biopsy (Fountain 
and Eberhard 1996; Kelley 2004; Younger 2004). It has been 
reported in carefully studied autopsy cases of PACNS that 
an asymptomatic extension of the inﬂ  ammatory process 
is possible and probably not rare (Lie 1997). Our case is 
in concordance with this assumption. Furthermore, there 
was no argument for a secondary cerebral angiitis due to 
infection, collagen-vascular disease or drug reaction (Kelley 
2004; Younger 2004). In addition, an Aβ-related angiitis 
(ABRA) could be also discussed. ABRA has been deﬁ  ned 
AB
CD
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Figure 1 A) Association of lymphocytic angiitis and amyloid deposits inﬁ  ltrating the wall of leptomeningeal vessel and perivascular cufﬁ  ng of mononuclear cells (hematoxylin-
eosin-safran original magniﬁ  cation X 10). B) Mononulear cells surrounding a non amyloid cortical vessel with severe intimal ﬁ  brosis occluding the lumen (hematoxylin-eosin-
safran original magniﬁ  cation X 20). C) Amyloid deposits present in the senile plaques immunostained for bA4 (original magniﬁ  cation X 40). D) Amyloid deposits present in the 
wall of vessels in the neocortex immunostained for bA4 (original magniﬁ  cation X 40). E) Neuroﬁ  brillary tangles immunostained for tau protein (original magniﬁ  cation X 10). 
F) Giant cell arteritis in the myocardium (hematoxylin-eosin-safran original magniﬁ  cation X 40).Vascular Health and Risk Management 2008:4(6) 1474
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by Scolding and colleagues (2005) as an association of a 
PACNS with CCA. ABRA affects older subjects compared to 
PACNS. Treatment of ACNS mainly depends on steroids and 
cyclophosphamide (Younger 2005). In our patient, steroids 
resulted in a partial improvement of the clinical status and 
normalization of the CSF and C-reactive protein indicating 
that the clinical deterioration of the late phase of the evolution 
was probably due to the cerebral angiitis.
Primary CAA is a frequent pathological process in aging 
causing mainly cerebral hemorrhage or more rarely an 
ischemic leucoencephalopathy (Vinters 1987; Kumar-Singh 
2008). A hypothetical causal relationship possibly exists 
between CAA and PACNS as both simultaneously occurred 
in seventeen reported cases of the literature representing 
almost 9% of patients with PACNS (Kelley 2004; Younger 
2004; Jennette and Falk 2007). It has been hypothesized 
that βA4 deposits may trigger an inﬂ  ammatory process by 
activating the cytokine cascade, stimulating macrophages, 
and inducing an inﬂ  ammatory reaction that can affect both 
amyloid and nonamyloid vessels (Fountain and Eberhard 
1996). CAA also occurs in up to 90% of cases of AD and 
is more frequent and severe in older patients (Vinters 1987; 
Kumar-Singh 2008). It is correlated with a higher frequency 
of hemorrhages and ischemic lesions. The pathophysiology 
of βA4 deposition in the CAA of AD is unknown but is 
probably different from that of βA4 deposition in senile 
plaques. Despite the high frequency of CAA in AD, the 
association of PACNS with CAA in the context of AD has not 
been reported so far (Brotman et al 2000; Jacobs et al 2004). 
In addition, although recent data suggest that patients with 
AD are prone to develop cerebrovascular diseases, autopsy 
series have not shown an abnormal frequency of PACNS in 
AD (Joachim et al 1988). In our patient, the relations between 
AD/CAA and PACNS remain unknown. A fortuitous asso-
ciation is possible. Alternatively, immune factors may have 
triggered the angiitis in a similar way as hypothesized in 
patients with CAA and PACNS. In this respect, the role 
of immunity and particularly complement fractions and 
cytokines has been discussed in AD (Dickson et al 1996; 
Gold et al 1998). However, the uniqueness of our case with 
AD in comparison with the relative frequency of the asso-
ciation of PACNS and primary CAA without AD suggests 
a different ability of amyloid deposits to trigger an immune 
reaction in AD.
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